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Abstract | Evolvability is the ability of a biological system to produce phenotypic variation that is both 8 
heritable and adaptive. It has long been the subject of anecdotal observations and theoretical work. In recent 9 
years, however, the molecular causes of evolvability have been an increasing focus of experimental work. 10 
Here we review recent experimental progress in areas as different as the evolution of drug resistance in 11 
cancer cells and the rewiring of transcriptional regulation circuits in vertebrates. This research reveals three 12 
major themes: the importance of multiple, genetic and non-genetic mechanisms to generate phenotypic 13 
diversity, of robustness in genetic systems, and of adaptive landscape topography. We also discuss the 14 
mounting evidence that evolvability can evolve, and the question of whether it evolves adaptively.  15 
 16 
[H1] Introduction 17 
Evolvability research is now entering its fourth decade. Although the term was first used as early as 1932, 18 
evolvability as a scientific subdiscipline of evolutionary biology is often associated with a 1989 article by 19 
Richard Dawkins1 describing what are now called digital organisms2. Today, research on evolvability is 20 
integral to multiple fields, including population genetics, quantitative genetics, molecular biology, and 21 
developmental biology. Not surprisingly then, this diversity of research has led to various definitions of 22 
evolvability3. We here focus on one of them, because we consider it the most fundamental: Evolvability is the 23 
ability of a biological system to produce phenotypic variation that is both heritable and adaptive. The 24 
definition is fundamental because, first, heritable phenotypic variation is the essential raw material of 25 
evolution. Second, unless a biological system has the potential to produce variation that is adaptive 26 
 2 
(beneficial) in some environments, adaptation by natural selection is impossible. Third, the definition is broad 27 
enough to apply to fields as different as population genetics and molecular biology, which study evolvability 28 
in different ways3. 29 
 30 
Most early evolvability research was theoretical or guided by few experimental studies1,3-11. This has changed. 31 
Research on evolvability is becoming increasingly experimental and driven by advances in high-throughput 32 
technologies (Box 1). The observations from such experiments are providing a mechanistic understanding of 33 
how living systems generate heritable adaptive variation12. We focus this Review on such experimental 34 
studies, which come from a diversity of fields, ranging from developmental to cancer biology. Many make no 35 
explicit mention of evolvability, yet they all shed light on the causes of evolvability, and some also on its 36 
evolution. They are relevant for phenomena as different as the evolution of antibiotic resistance in bacteria, 37 
and the evolutionary rescue of populations threatened by climate and other environmental change. Their 38 
insights fall into three major categories, which provide a scaffold for this Review. 39 
 40 
The first major category encompasses molecular mechanisms that create phenotypic heterogeneity, and do so 41 
not just through DNA mutations, but even in the absence of such mutations. These mechanisms have become 42 
central to evolvability research, because they allow isogenic populations [G] to create phenotypic variation, 43 
some of which may facilitate survival in new or rapidly changing environments, and may thus provide time 44 
for an advantageous phenotype to be reinforced or stabilized via DNA mutation, gene duplication, 45 
recombination, or epigenetic modification. The second category of evidence revolves around robustness, 46 
which is central to evolvability, because it allows an evolving population to explore new genotypes without 47 
detrimentally affecting essential phenotypes. The resulting genotypic diversity may serve as a springboard for 48 
subsequent mutations to generate novel phenotypes, or it may bring forth new phenotypic variation when the 49 
environment changes. The third category of evidence regards the topographical features of an adaptive 50 
landscape, such as its smoothness, and a population’s location within such a landscape. These factors 51 
determine the amount of adaptive phenotypic variation that mutation can bring forth. Adaptive landscapes 52 
 3 
provide a useful geometric framework to encapsulate genotype-phenotype (or fitness) relationships that affect 53 
evolvability. 54 
 55 
Unfortunately, space constraints prevent us from reviewing other important aspects of evolvability research, 56 
including the roles of phenotypic plasticity [G] , organismal development, modularity [G] , and pleiotropy 57 
[G] , as well as theoretical advances. Additionally, we frame our Review primarily around mechanisms of 58 
pre-mutation evolvability [G] and mechanisms that do not require genetic change, although we briefly 59 
discuss some mechanisms of post-mutation evolvability [G] , where recombination plays an especially 60 
important role13. 61 
 62 
[H1] Phenotypic heterogeneity 63 
Heritable phenotypic variation is the raw material of natural selection, and the best-known mechanisms to 64 
create such variation are DNA mutation and recombination. However, because the role these mechanisms 65 
play in generating phenotypic variation is well established and has been extensively reviewed13,14, we here 66 
focus on another class of mechanisms whose astonishing diversity is only beginning to come to light through 67 
recent experimental work15. These mechanisms create phenotypic heterogeneity without creating genetic 68 
variation. 69 
 70 
Non-genetic mechanisms to create phenotypic heterogeneity can be found in many processes affecting the 71 
expression of genetic information. We review four such mechanisms: stochastic gene expression, errors in 72 
protein synthesis, epigenetic modifications, and protein promiscuity. Each mechanism can create phenotypic 73 
variation in a population of genetically identical individuals16. Such variation can for example provide a 74 
competitive advantage to subpopulations with adaptive phenotypes in fluctuating environments17,18. These 75 
phenotypes may themselves be heritable, eventually made permanent by mutation or epigenetic modification, 76 
or they may simply ‘buy time’ for a population to adapt in other ways to an environmental challenge (Fig. 77 
1a). 78 
 4 
 79 
[H2] Stochastic gene expression. Stochastic gene expression, or gene expression noise [G] has multiple 80 
causes, including the efficiency of transcription and translation19,20, as well as the regulation of gene 81 
expression by low-abundance molecules whose numbers fluctuate randomly in a cell21 (Fig. 1b). It can create 82 
non-genetic, adaptive diversity in phenotypes as diverse as viral latency [G] , bacterial competence [G] and 83 
antibiotic resistance, as well as drug resistance in cancer22-24. 84 
 85 
One example where stochastic gene expression causes adaptive phenotypic variation is persistence, where 86 
some cells in an isogenic population exhibit a physiologically dormant phenotype called a persister 87 
phenotype25. This phenotype is adaptive, because a dormant subpopulation has the potential to survive drugs 88 
that require active growth for killing, affording the persistent subpopulation time to acquire resistance-89 
conferring DNA mutations. This was recently demonstrated in a laboratory evolution experiment of 90 
Escherichia coli populations subjected to intermittent exposures of ampicillin26, in which persistence served 91 
as a stopgap until some individuals acquired resistance-causing mutations.  92 
 93 
Persistence arises in only a small fraction of a population, so one might think that the resulting population 94 
bottleneck [G] would hinder evolvability by reducing the supply of beneficial mutations. However, a recent 95 
study of non-small-cell lung cancer indicates that this need not be the case27. These cells stochastically 96 
express a persistent phenotype, mediated by an altered chromatin state28. A population derived from one of 97 
these cells was exposed to the drug erlotinib, which resulted in the formation of multiple persistent 98 
subpopulations. Seventeen of these subpopulations were later expanded in isolation from each other until 99 
drug resistance emerged through DNA mutations. Genetic analysis of the resistant clones uncovered several 100 
distinct resistance mechanisms, indicating that several evolutionary paths to resistance remained despite the 101 
population bottleneck. In sum, persistence can facilitate evolvability, because it allows some individuals 102 
(individual cells in this example) to survive long enough to experience adaptive genetic change.  103 
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 104 
Rare-cell-variability is similar to persistence, in that a subpopulation of cells stochastically expresses a 105 
phenotype that facilitates the evasion of drug treatment28,29. It is different from persistence, in that the 106 
subpopulation is not dormant, but rather exhibits a transient transcriptional state that may include the 107 
expression of resistance-conferring genes. For example, in a study of resistance evolution to the drug 108 
vemurafenib in human melanoma, rare cells transiently expressed one or several such genes prior to drug 109 
exposure, making them ‘pre-resistant’.24 After four weeks of drug exposure, stably resistant colonies emerged 110 
that expressed these genes at uniformly high levels, and in a semi-coordinated fashion. For instance, of 1,456 111 
genes known to contribute to resistance, pre-resistant cells expressed 72. After four weeks of drug exposure, 112 
this number rose to 966. These changes were not caused by DNA mutations. Rather, drug exposure initiated 113 
epigenetic cellular changes that stabilized the transiently resistant state. The transient expression of 114 
resistance-conferring genes in rare cells is not limited to melanoma, but is also found in unrelated cancer cell 115 
types, suggesting that the epigenetic conversion of a rare, transient transcriptional state to a stably resistant 116 
state may be a common mechanism of evolvability in cancer30. Such stabilization of a new phenotype, even if 117 
temporary, may facilitate more permanent stabilization through genetic mutations. Examples like these are 118 
closely related to the phenomenon of genetic assimilation [G] , which has been studied since the 1950s31,32. 119 
 120 
Stochastic gene expression may also facilitate evolvability by changing how strongly mutations affect fitness, 121 
and in particular by enhancing the positive effects of beneficial mutations33. This was recently demonstrated 122 
using synthetic gene circuits in Saccharomyces cerevisiae34, which were engineered to exhibit varying 123 
degrees of expression heterogeneity in an antifungal resistance gene. Populations harbouring a version of a 124 
circuit with high expression heterogeneity were compared to those harbouring a circuit with low expression 125 
heterogeneity. During an evolution experiment where populations were exposed to increasing concentrations 126 
of the antifungal drug fluconazole, high-heterogeneity populations went extinct less often and evolved higher 127 
fluconazole resistance than low-heterogeneity populations. At least partly responsible were the increased 128 
beneficial effects of flucanozole resistance mutations in high-heterogeneity populations, because the same 129 
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resistance mutations conferred greater resistance when expressed with high expression heterogeneity than 130 
with low heterogeneity. Altering the phenotypic effects of mutations is therefore another route by which 131 
stochastic gene expression can facilitate evolvability33. 132 
 133 
[H2] Errors in protein synthesis. In addition to stochastic gene expression, protein synthesis errors can also 134 
create non-genetic phenotypic heterogeneity. Such errors come in many forms and occur at multiple stages of 135 
protein synthesis, including nucleotide misincorporation during transcription, tRNA misacylation during 136 
translation, and kinetic trapping [G] during protein folding35. Translation is particularly error-prone, with 137 
rates of mistranslation exceeding those of DNA point mutations by several orders of magnitude. Such errors 138 
are also called phenotypic mutations36, and they include missense, read-through, and frameshift mutations. 139 
Phenotypic mutations can facilitate evolvability, because they create variation in a protein pool expressed 140 
from the same gene, and some of this variation may be adaptive (Fig. 1c). For example, elevated 141 
mistranslation rates in Mycobacterium tuberculosis generate variation in the beta subunit of RNA 142 
polymerase, which increases resistance to the antibiotic rifampicin37. Similarly, mistranslation of CUG 143 
codons in the fungal pathogen Candida albicans generates variation in cell surface proteins that facilitate 144 
evasion of the host’s immune system38.  145 
 146 
A special kind of mistranslation error is stop-codon readthrough [G] , which is a common mechanism for 147 
generating protein variation in species as different as yeast, fly and human39,40. In fungi, for example, it can 148 
lead to the expression of cryptic peroxisomal signalling motifs that create variation in the cellular localization 149 
of proteins40. In crustacea and hexapods, DNA sequences downstream of an affected stop codon are often 150 
evolutionarily conserved, suggesting that stop-codon readthrough occurs frequently enough to affect the 151 
evolution of cryptic sequences41,42. 152 
 153 
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Protein synthesis errors not only enhance evolvability by increasing protein diversity, they can also help pave 154 
the way for subsequent adaptive genetic change43,44. An example comes from the S. cerevisiae protein IDP3, 155 
an NADP-dependent isocitrate dehydrogenase that localizes to the peroxisome45. The protein originated in an 156 
ancient yeast whole-genome duplication, and diverged from its cytosolic ancestor IDP2 by acquiring a C-157 
terminal peroxisomal targeting signal, while IDP2 remained cytosolic. Yeast species that diverged before the 158 
whole-genome duplication possess only a cytosolic IDP2 gene, but in four of these species the gene contains 159 
a cryptic peroxisomal targeting signal in the 3′ untranslated region. This signal can be revealed via a +1 160 
translational frameshift that bypasses the stop codon, which exposes the mistranslated protein to selection for 161 
peroxisomal targeting and function, and can, for example, lead to an increase in the strength of the 162 
peroxisomal signalling motif45. The frameshift is induced by a sequence context that is prone to ribosomal 163 
slippage, and that is also prone to single nucleotide deletions that mimic the effect of the frameshift on 164 
protein sequence. This correlation between phenotypic and genotypic mutations thus facilitated the evolution 165 
IDP3: Before the whole-genome duplication, IDP2 could already be expressed in two locations: in the 166 
cytosol through faithful translation, and in the peroxisome through mistranslation. After the whole-genome 167 
duplication, the peroxisomal localization and function was made permanent via a single base deletion in one 168 
of the gene copies.  169 
 170 
[H2] Epigenetic modifications. Phenotypic heterogeneity can also be caused by epigenetic changes, such as 171 
methylation of DNA and histones, alteration of chromatin structure, and the changes in protein conformation 172 
known as prions [G]. For example, the prion [PSI+] in S. cerevisiae is an aggregated conformation of the 173 
translational suppressor protein Sup35, which can be inherited by forming inactive complexes that convert 174 
other Sup35 proteins to the same inactive state18. Such aggregation reduces translational fidelity, which 175 
causes translational errors that include stop-codon readthrough events and frameshifts in other proteins46 (Fig. 176 
1d). Some of these errors reveal cryptic genetic variation [G] , producing phenotypes that are heritable and 177 
that can be adaptive18,47. For example, [PSI+] can improve growth on a variety of carbon and nitrogen sources, 178 
and in various temperatures and stress conditions18,48. The phenotypes induced by [PSI+] and other prions can 179 
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persist for generations, which provides opportunity for the phenotypes to be reinforced by mutation or 180 
recombination, or to interact with existing genetic variation or new mutations to form novel, potentially 181 
adaptive phenotypes47,49. Recent research in this area has greatly expanded the repertoire of known prions49-51, 182 
elucidated the mechanisms by which they confer a selective advantage52-54, and uncovered alternative forms 183 
of protein-based inheritance55-57. For instance, the first bacterial prion has recently been identified50. It is the 184 
transcription terminator Rho of Clostridium botulinum, which can take on one of two conformations, a 185 
soluble form that does not impact transcription, and an aggregate prion form that can self-propagate and that 186 
alters transcription, causing genome-wide transcriptomic changes. Its discovery raises the exciting possibility 187 
that this cause of evolvability is ancient and predates the origin of eukaryotes. 188 
 189 
The methylation of DNA and histones are heritable epigenetic modifications, which create phenotypic 190 
variation that can be adaptive58,59. A recent example comes from the study of intra-tumour heterogeneity in 191 
cancer60. Proliferative potential varies among cancer cells within the same tumour, and those cells that 192 
preserve proliferative potential can drive long-term tumour growth. Some of this variation is caused by an 193 
epigenetic modification to an enhancer [G] that modulates the expression of the linker histone H1.0, which 194 
is involved in the compaction of chromatin. Specifically, DNA methylation of the enhancer represses the 195 
expression of the linker histone. This destabilizes nucleosome–DNA interactions, which de-represses the 196 
expression of oncogenes that support proliferative potential. Thus, variation in the epigenetic modification of 197 
a regulatory element creates variation in chromatin structure, some of which facilitates cancer cell self-198 
renewal. This epigenetic cause of intra-tumour heterogeneity is found in dozens of cancers60, and it is just one 199 
of several epigenetic causes of phenotypic heterogeneity in this disease59. 200 
 201 
[H2] Protein promiscuity. A fourth cause of evolvability-enhancing phenotypic heterogeneity is protein 202 
promiscuity61,62. Promiscuous proteins have one primary adaptive function and other secondary latent 203 
functions. Prominent examples include enzymes with ‘moonlighting’ catalytic activities63,64, such as bacterial 204 
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carbonic anhydrase II, which mainly catalyzes the reversible hydration of carbon dioxide, but also exhibits 205 
promiscuous activity toward esters61. Promiscuity can facilitate evolvability, because it provides a reservoir 206 
of potentially adaptive protein activities that can be enhanced by gene duplication, when such duplications 207 
are followed by mutations that refine different activities in different duplicates. For example, in S. cerevisiae, 208 
two transcription factors that are products of a past gene duplication regulate the genes involved in maltose 209 
metabolism and the genes involved in palatinose metabolism65. These duplicates arose from a single 210 
promiscuous transcription factor that regulated the expression of both the maltose- and palatinose-specific 211 
genes. After gene duplication, two single-nucleotide mutations in the DNA binding domain of one of the 212 
duplicates altered its binding specificity, such that it could no longer bind the promoters of the maltose-213 
specific genes. Mutations in the coding region of the other duplicate weakened its activity toward maltose, 214 
such that it could only activate the maltose-specific genes, because their promoters contained multiple 215 
binding sites for the protein, which compensated for its reduced activity. Gene duplication thus facilitated the 216 
partitioning of the promiscuous activity of a single transcription factor among its duplicates.  217 
 218 
Sometimes duplication may not even be needed to reinforce a promiscuous function66,67. This is especially 219 
true for regulatory elements. For example, the Drosophila santomea gene Neprilysin-1 evolved a novel 220 
expression pattern in the fly’s optic lobe via a small number of mutations to an existing enhancer68. 221 
Reconstruction of the enhancer’s ancestral state revealed its promiscuous activity in the optic lobe, indicating 222 
that these mutations did not generate new enhancer activity de novo, but rather refined one of the enhancer’s 223 
existing, latent activities. 224 
 225 
In sum, these examples show how various forms of phenotypic heterogeneity — caused by stochastic gene 226 
expression, errors in protein synthesis, epigenetic modifications, and protein promiscuity — facilitate the 227 
exploration of novel phenotypes. Some of these phenotypes may be adaptive, and may be made permanent by 228 
selection for genetic or epigenetic changes that reinforce the phenotype. We emphasize that many other 229 
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mechanisms to regulate molecular processes exist, and given the adaptive benefits of phenotypic 230 
heterogeneity, it is likely that they will also be implicated in producing such heterogeneity. 231 
 232 
[H1] Robustness 233 
Robustness to DNA mutations can be viewed as a dual, converse, or opposite property to non-genetic 234 
phenotypic heterogeneity. Whereas non-genetic phenotypic heterogeneity implies that phenotypic variation 235 
exists in the absence of genetic variation, robustness implies that phenotypic variation does not exist in the 236 
presence of genetic variation, because a phenotype is robust to genetic change.  237 
 238 
Many phenotypes are to some extent robust to mutations69,70. Examples include the structure and biological 239 
activity of macromolecules71, the gene expression patterns of regulatory networks72, and the ability of a 240 
metabolism to synthesize biomass73. Such robustness can also be enhanced in various ways. For example, 241 
DNA mutations that enhance protein stability can also enhance robustness, because enhanced protein stability 242 
increases the range of mutations a protein can experience while still folding into its native structure71. Gene 243 
duplication can also enhance robustness, because it causes gene functions to become redundant, and can thus 244 
increase the incidence of mutations that can be tolerated by either duplicate74 (but see refs 75,76). Chaperones 245 
[G] such as the eukaryotic protein Hsp90 enhance robustness in organisms as diverse as fruit flies, cave fish, 246 
plants and bacteria77-82, although such buffering may not occur in all organisms and may not affect all genetic 247 
variation78,83.  248 
 249 
In each of these cases, DNA mutations can cause genetic diversity without changing a phenotype. Such 250 
cryptic genetic variation can facilitate evolvability in at least three ways. First, cryptic genetic variation may 251 
be revealed as phenotypic variation, for example via the partial loss of function of a chaperone or via the 252 
appearance of a prion, or when the environment changes18,42,47,78,81,84,85. Because these phenotypes are 253 
occasionally exposed to selection, cryptic genetic variation may be enriched for adaptations42. Second, cryptic 254 
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genetic variation provides many distinct genetic backgrounds in which the effects of new mutations can 255 
manifest themselves86,87. This can be advantageous because the same mutation can have different phenotypic 256 
effects — neutral, beneficial, or detrimental — in different genetic backgrounds, a phenomenon caused by 257 
frequent epistatic interactions [G] (non-additive interactions) among mutations. Finally, cryptic genetic 258 
variation may give rise to new phenotypic variation via recombination. 259 
 260 
The study of robustness has a long history in evolvability research69,88, but recent experimental work has 261 
greatly expanded our mechanistic understanding of how robustness facilitates the generation of adaptive 262 
phenotypic variation. These advances largely result from technological progress in areas such as deep 263 
mutational scanning and ancestral protein reconstruction (Box 1). We highlight recent examples from 264 
individual macromolecules, from interactions between macromolecules and their ligands, and from entire 265 
gene regulatory networks. 266 
 267 
The C2H2 zinc finger is the most prominent protein domain [G] in many metazoans, but not in other 268 
eukaryotes. It occurs in C2H2 zinc finger transcription factors, where multiple copies of this domain are 269 
typically arranged in tandem, such that each domain contacts three or more DNA bases, the identity of which 270 
is determined by four base-contacting amino acids in the domain’s alpha helix. The diversity of DNA 271 
sequences recognized by metazoan C2H2 zinc fingers far exceeds that of other eukaryotic C2H2 zinc fingers, 272 
and recent research implicates robustness in their expansion and diversification89. Specifically, in metazoans, 273 
non-base-contacting amino acids of the C2H2 zinc finger domain form hydrogen bonds with the DNA 274 
phosphate backbone to enhance binding energy. By contrast, the binding energy of other eukaryotic C2H2 275 
zinc fingers depends primarily on base-contacting amino acids. This suggests that the non-base-contacting 276 
amino acids of metazoan C2H2 zinc fingers confer robustness of DNA binding to mutations in base-277 
contacting amino acids, which facilitates the diversification of DNA binding preferences.  278 
 279 
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The evolution of steroid receptor binding preferences provides another example of how robustness facilitates 280 
evolvability. Steroid receptors are transcription factors that can be classified according to their binding 281 
preference for oestrogen response elements or steroid response elements. These two response elements are 282 
6nt-long DNA sequences that differ by just two nucleotides. The ancestral steroid receptor from which all 283 
steroid receptors descended more than 450 million years ago binds oestrogen response elements90. After this 284 
protein duplicated, one daughter protein retained specificity to oestrogen elements, whereas the other evolved 285 
a preference for steroid response elements. This shift in specificity required eleven substitutions outside of 286 
the DNA binding domain and three substitutions within it. The eleven mutations outside of the DNA binding 287 
domain did not affect DNA binding specificity — specificity was robust to genetic changes — but they had 288 
another important consequence: they dramatically altered the number of mutational variants capable of 289 
binding steroid response elements. Specifically, out of 160,000 possible mutational variants of the ancestral 290 
protein without the 11 mutations, only 41 specifically bound steroid response elements. By contrast, of the 291 
same 160,000 mutational variants of the ancestral protein with the 11 mutations, 829 specifically bound 292 
steroid response elements, and these variants were accessible via fewer mutations91. The mutational 293 
neighbourhoods of the two proteins were therefore dramatically different, and it was the robustness to 294 
mutation that facilitated access to the mutational neighbourhood that conferred higher evolvability (Fig. 2). 295 
 296 
Not only are regulatory proteins robust to mutation, so too are the regulatory elements they target87,92. For 297 
example, eukaryotic transcription factors typically bind dozens to hundreds of distinct nucleic acid 298 
sequences93, which tend to be mutationally interconnected, such that a mutation to a sequence that binds a 299 
transcription factor will often generate another sequence that also binds the transcription factor87. This 300 
robustness facilitates the accumulation of genetic diversity in binding sites94, which provides distinct genetic 301 
backgrounds in which to test new mutations. Some of these mutations generate binding sites for other 302 
transcription factors87, which may lead to adaptive gene expression changes. 303 
 304 
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Gene expression patterns themselves are highly robust, not only to mutations in binding sites, but also to 305 
wholesale changes in the number, identity, and orientation of binding sites within regulatory regions95, and 306 
thus to changes in the structure of gene regulatory networks96. Modelling work has long anticipated that such 307 
robustness can facilitate evolvability97,98, but empirical support for this possibility was only recently 308 
provided99. Specifically, the highly conserved fungal transcription factor Ndt80 underwent a pronounced 309 
switch in function from an ancestral role regulating meiosis and sporulation to a derived role regulating 310 
biofilm formation. Experiments with six different extant yeast species suggest that this shift was not caused 311 
by a change in the binding specificity of Ndt80, but rather by gains and losses of binding sites for Ndt80. 312 
These changes preserved the ancestral role of Ndt80 but allowed the regulatory network controlling meiosis 313 
and sporulation to sample many architectural configurations. This sampling facilitated the discovery of a 314 
network configuration that supported the derived role of biofilm production in Candida albicans.  315 
 316 
In sum, these examples illustrate that robustness creates opportunities for the exploration of novel genotypes, 317 
some of which constitute or lead to new adaptations. Other pertinent examples include recent studies of 318 
robustness in viral proteins100,101, bacterial enzymes102, tumour suppressor genes103, protein–protein 319 
interactions104,105 and gene regulatory networks106. 320 
 321 
[H1] Adaptive landscape topography 322 
An adaptive landscape is an analogy to a physical landscape, in which each location or coordinate in a 323 
physical space corresponds to a genotype in an abstract genotype space [G] 107, and where the elevation at 324 
this location corresponds to the fitness of this genotype108. One can view adaptive evolution as a process 325 
where populations of ever-changing genotypes explore such a landscape through random DNA mutations and 326 
recombination, and where natural selection helps such populations discover peaks or plateaus of high fitness. 327 
Adaptive landscapes are central to evolvability research, because the topography of an adaptive landscape, 328 
and a population’s location within a landscape, determine the amount of beneficial phenotypic variation that 329 
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mutations can create. A smooth, single-peaked landscape facilitates evolvability, because mutation can bring 330 
forth beneficial phenotypic variation from anywhere in the landscape, except atop a global peak (Fig. 3a). In 331 
contrast, a rugged landscape can hinder evolvability, because the local peaks it contains may attract an 332 
evolving population and preclude the generation of further beneficial phenotypic variation (Fig. 3b). 333 
Moreover, the shape of an adaptive peak — concave [G] versus convex [G] — affects the amount of 334 
beneficial phenotypic variation that mutation can bring forth as an evolving population ascends the peak. 335 
Until recently, most work on adaptive landscapes was theoretical, but experiments are now being increasingly 336 
used to characterize the topography of adaptive landscapes109. Some of these studies use organismal fitness to 337 
define the surface of a landscape110,111, whereas others use molecular phenotypes, such as the enzymatic 338 
activity112,113 or binding affinity114,115 of a protein, and are therefore also referred to as genotype–phenotype 339 
landscapes116. The pace of this work is still accelerating, and we focus on the most recent such work.  340 
 341 
Perhaps the most important factor affecting landscape ruggedness and the shape of adaptive peaks is epistasis 342 
— non-additive interactions among two or more mutations117,118. Epistasis can take different forms (Fig. 343 
3c,d), and can occur with mutations that are individually deleterious or beneficial. For example, negative 344 
epistasis amongst beneficial mutations occurs when the combined effect of the mutations is smaller than the 345 
sum of the individual mutational effects119,120 (Fig. 3c). It is also referred to as antagonistic or diminishing 346 
returns epistasis. Positive epistasis amongst beneficial mutations occurs when the combined effect of the 347 
mutations is larger than the sum of the individual mutational effects (Fig. 3c). It is also referred to as 348 
synergistic epistasis. The terminology used to describe epistasis can be confusing (e.g., synergistic epistasis is 349 
also used to describe negative epistasis amongst deleterious mutations121), but mathematically the definition 350 
of positive and negative epistasis is straightforward. Epistasis amongst two mutations A and B can be 351 
quantified as ε = fab + fAB – fAb – faB, where f is the phenotype or fitness of the ‘wild type’, double mutant, and 352 
single mutant genotypes, respectively. Negative epistasis occurs when ε < 0, whereas positive epistasis occurs 353 
when ε > 0.  354 
 355 
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Another important form of epistasis is sign epistasis122. It occurs when the sign — beneficial (+) or 356 
detrimental (–) — of a double mutation differs from that of one or both of the constituent single mutations. 357 
For example, whereas both single mutations may be individually detrimental, they may be jointly beneficial. 358 
Sign epistasis creates local valleys or peaks and thus ruggedness in an adaptive landscape (Fig. 3d)118. In 359 
doing so, it can affect the amount of adaptive variation accessible to a population, a population’s evolutionary 360 
trajectory, and its ability to reach a global peak. For example, global peaks may be inaccessible if all 361 
evolutionary trajectories to them require traversing one or more adaptive valleys, which is disfavoured by 362 
natural selection and possible only under restricted conditions123,124. With some exceptions125-127, sign 363 
epistasis thus reduces evolvability. 364 
 365 
A fundamental challenge in mapping an adaptive landscape is that the number of genotypes in a typical 366 
genotype space is so vast that their phenotype or fitness cannot usually be exhaustively measured. One 367 
approach to overcome this challenge uses experimental evolution of whole organisms128, where the change in 368 
a population’s mean fitness and genotypic composition is monitored while the population evolves for 369 
hundreds or thousands of generations in the laboratory. Such experiments show that even though specific 370 
genetic changes that cause fitness increases are usually not predictable, the evolutionary trajectory of mean 371 
fitness increases can be highly predictable129-132, suggesting that suitable statistical methods may be able to 372 
infer general statistical properties of adaptive landscape topography133,134. Additionally, experimental 373 
evolution demonstrates that a population’s mean fitness increase — a proxy for evolvability — depends 374 
primarily upon the fitness of the starting genotype, and also upon the starting genotype itself (i.e., from which 375 
location a population begins to explore an adaptive landscape)129,135. 376 
 377 
An important limitation of this method is that it does not allow the detailed mapping of adaptive landscape 378 
topography, because evolving populations typically harbour a large number of mutations whose contributions 379 
to fitness are not easily disentangled136,137. Such a mapping requires more targeted approaches. One such 380 
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approach is to engineer all possible genotypes in a small region of a landscape, for example by using all 381 
combinations of the presence or absence of mutations that occurred along an adaptive evolutionary pathway, 382 
or more comprehensively by using all possible combinations of mutations at a fixed number of nucleotide or 383 
amino acid sites109 (Fig. 3e). One pertinent recent study constructed an adaptive landscape from all possible 384 
combinations of 13 amino-acid-changing mutations at six amino acids in the heat-shock protein Hsp90 of S. 385 
cerevisiae in a high-salt environment138. The resulting landscape provides several fundamental insights into 386 
the evolvability of Hsp90 in this challenging environment. First, the landscape is dominated by epistasis: not 387 
a single pairwise interaction between mutations is additive. These epistatic interactions include both positive 388 
and negative epistasis, as well as sign epistasis. Second, the sign epistatic interactions produce landscape 389 
ruggedness, with five local peaks and a single global peak that conveys a 10% increase in yeast growth rate 390 
on high salt, relative to the wild-type genotype. Third, although the landscape is moderately rugged, it is still 391 
highly navigable, as shown by simulated adaptive walks [G]. These walks reveal that the global peak can be 392 
reached from nearly any starting point in the landscape. One important exception is the wild-type genotype, 393 
because adaptive walks starting from this genotype tend to converge to a local peak but not to the global 394 
peak. Taken together, these observations show how epistasis can generate landscape ruggedness, and that a 395 
population’s location within such a rugged landscape affects the ability of mutation to bring forth heritable, 396 
adaptive phenotypic variation. 397 
 398 
Another approach to constructing adaptive landscapes is based on deep mutational scanning139, in which 399 
phenotypes are assayed for a large number of mutational variants of a single, typically wild-type genotype 400 
(Fig. 3f). This approach thus characterizes the immediate neighbourhood of an adaptive peak. It has been 401 
used extensively in recent years, for phenotypes as different as the ‘splicing-in’ of an exon116, the binding 402 
affinity114,115 and enzymatic activity112,113 of a protein, as well as the fitness of an entire organism84,110,111. For 403 
example, a recent study employed a deep mutational scan of the wild-type sequence of the green fluorescent 404 
protein from the jellyfish Aequorea victoria, using fluorescence level to define the landscape’s surface140. 405 
This analysis revealed a single, narrow peak centred on the wild-type sequence, with three quarters of the 406 
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single-mutant sequences displaying reduced fluorescence, and half of the sequences with four mutations 407 
showing no fluorescence at all. The analysis also revealed abundant negative epistasis, and very little positive 408 
epistasis. Negative epistasis produces concave peaks141 (Fig. 3c), which reduces evolvability when a 409 
population approaches an adaptive peak, because the amount of adaptive phenotypic variation accessible via 410 
mutation decreases. Conversely, positive epistasis helps create convex peaks and facilitates evolvability. 411 
These modes of epistasis also have implications for mutational robustness141,142. The concave peaks formed 412 
by negative epistasis confer robustness, because individual mutations to genotypes on such peaks have small 413 
fitness effects. By contrast, the convex peaks formed by positive epistasis confer sensitivity to mutation, 414 
because individual mutations to genotypes on such peaks have large fitness effects. With few 415 
exceptions143,144, a bias towards negative epistasis is among the most commonly reported features of 416 
experimentally characterized adaptive landscapes110,111,114,115,138,140,141, in agreement with the diminishing 417 
returns epistasis regularly observed in laboratory evolution experiments119,120,130-132. 418 
 419 
Even though deep-mutational scanning and related techniques are powerful, they still render a typical 420 
genotype space sparsely sampled, and extrapolating insights from the resulting incomplete landscapes to 421 
complete landscapes is challenging138,145,146. Not affected by this limitation are small genotype spaces, where 422 
it is possible to assay the phenotypes of all possible genotypes147,148 (Fig. 3g). One such genotype space is that 423 
of short transcription factor binding sites, where one can measure how strongly a transcription factor binds to 424 
thousands of different DNA sequences93. Such information is not just available for one, but for thousands of 425 
transcription factors from multiple species149. Binding strength is an important molecular phenotype, because 426 
it is a proxy for a factor’s ability to activate or repress a target gene, and the gene expression patterns that 427 
emerge from such binding events embody fundamental biological processes, including those in development, 428 
physiology, and behaviour. Importantly, the location and timing of these gene expression patterns can be 429 
fine-tuned, or altogether transformed, by mutations that affect the strength of transcription factor–DNA 430 
interactions150,151. The mapping of DNA sequence to binding strength can therefore be thought of as an 431 
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adaptive landscape, in which mutation and natural selection optimize the capacity of a DNA sequence to bind 432 
a transcription factor. 433 
 434 
A recent study analyzed the topographies of more than 1000 such landscapes94. They contained little sign 435 
epistasis, and therefore typically comprised only a single peak. Similar to the landscape of yeast Hsp90 in 436 
high salinity138, these landscapes were highly navigable. Their global peaks tended to be accessible from 437 
throughout the landscape via a series of ‘uphill’ mutational steps. Indeed, even at the furthest mutational 438 
distance from a global peak, more than 20% of all possible mutational paths were accessible. Such smooth 439 
landscapes facilitate evolvability, because mutation can readily bring forth beneficial phenotypic variation, 440 
regardless of a population’s location on the landscape.  441 
 442 
A limitation to these approaches, as compared to experimental evolution, is that an adaptive landscape for a 443 
single binding site or an individual gene has many fewer dimensions than an adaptive landscape for an entire 444 
genome. This is important, because the valleys that separate adaptive peaks in low-dimensional landscapes 445 
may not do so in high-dimensional landscapes. The reason is that increased dimensionality may create 446 
mutational paths that bridge adaptive valleys, or that transform local adaptive peaks into saddle points [G]. 447 
Such extra-dimensional bypasses [G] increase the accessibility of adaptive peaks, and thus increase 448 
evolvability5. Long the subject of theoretical research5,152, extra-dimensional bypasses have recently been 449 
uncovered in an adaptive landscape of binding affinity for the protein GB1 of Streptococcal bacteria153. The 450 
authors analyzed all 204 protein variants of 4 amino acid sites, and sampled ~20,000 pairs of mutations that 451 
exhibited reciprocal sign epistasis (Fig. 3d). Of these pairs, ~15% exhibited an extra-dimensional bypass 452 
when one of the other two amino acid sites was considered. Such an increase in the mutational accessibility 453 
of adaptive peaks suggests that increasing the dimensionality of adaptive landscapes from that of individual 454 
binding sites or genes to that of entire genomes reduces landscape ruggedness and thus enhances evolvability. 455 
 456 
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The examples highlighted here are only a small sample of recent experimental studies of adaptive landscapes, 457 
with other pertinent examples in systems as different as drug delivery vehicles154 and cancer155. We anticipate 458 
that the resolution and scale of such landscapes will continue to increase as high-throughput genotyping and 459 
phenotyping technologies advance (Box 1).  460 
 461 
[H1] Evolvability evolving 462 
Any cause or mechanism of evolvability could in principle itself be subject to evolutionary change. Three 463 
questions about such change are germane. First, can the mechanism evolve in principle, i.e., is there genetic 464 
variation in it? Second, does it evolve, either in nature or in the laboratory? Third, is a change in evolvability 465 
itself adaptive? Or is it instead a by-product of other adaptations or of non-adaptive processes, such as 466 
developmental constraints, mutation bias, or genetic drift? We discuss existing evidence pertaining to these 467 
questions for each of our three major causes of evolvability.  468 
 469 
[H2] Evolution of phenotypic heterogeneity. Genetic mechanisms that create phenotypic heterogeneity can 470 
evolve. For example, the rate of DNA mutation is itself subject to evolutionary change156,157, because the 471 
DNA repair enzymes that keep DNA mutations in check can themselves undergo mutations that lead to 472 
elevated mutation rates. Such evolution can be adaptive in novel environments156,158, for example during 473 
E.coli’s colonization of the mouse gut159. Similarly, increases in recombination rate can accelerate a 474 
population’s rate of adaptation — a proxy for evolvability — either by creating more beneficial allele 475 
combinations or by helping to eliminate deleterious mutations160.  476 
 477 
Non-genetic mechanisms of phenotypic heterogeneity can also evolve161. For example, gene expression noise 478 
levels vary genetically with promoter strength and with the strength of transcription factor binding sites162; 479 
stop-codon readthrough rates vary with stop-codon identity (UAG, UAA or UGA), the surrounding sequence 480 
context, and the structure of mRNA163; the formation and activity of prions varies according to the presence 481 
of aggregation-prone amino acid sequences in prion-forming protein domains, such as glutamine/asparagine-482 
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rich sequences164; and protein promiscuity varies with a protein’s coding sequence61,67,105. Thus, in each case, 483 
the factors that can affect phenotypic heterogeneity are genetically encoded, and can therefore evolve. 484 
 485 
What is more, mechanisms that create phenotypic heterogeneity do evolve, both in laboratory experiments 486 
and in nature. For example, the evolution of increased gene expression noise in S. cerevisiae has been 487 
reported for antifungal resistance genes in the lab34 and for plasma-membrane transporters in the wild165. 488 
Experimental evolution of synthetic E. coli promoters to specific mean expression levels results in promoters 489 
with low expression noise, suggesting that the noisy expression of many natural E. coli promoters is an 490 
evolved property166. Other forms of phenotypic heterogeneity have also been successfully evolved in the lab, 491 
including protein promiscuity in bacteriophage λ (ref 67) and the stochastic switching of colony morphology 492 
in Pseudomonas fluorescens17.  493 
 494 
At least in some instances, the evolvability conferred by phenotypic heterogeneity may have evolved because 495 
it was adaptive. For example, in the experimental evolution of populations of S. cerevisiae exposed to 496 
antifungal stress, increased expression noise evolved in the synthetic regulatory circuits controlling an 497 
antifungal resistance gene, because it enhanced the adaptive value of beneficial mutations34. Similarly, in the 498 
experimental evolution of populations of P. fluorescens exposed to environmental fluctuations, the stochastic 499 
switching of colony morphology evolved as an adaptive bet-hedging strategy17. Such a strategy was also 500 
observed in the experimental evolution of E. coli under antibiotic stress, where the stochastic expression of 501 
persister cells evolved to facilitate survival in high concentration of antibiotic26. In other instances, 502 
evolvability is a by-product of other adaptations. For example, promiscuity in the host-recognition protein of 503 
bacteriophage λ evolved as a by-product of selection for increased absorption to the virus’ native cell surface 504 
receptor67. Specifically, the same mutations that increased absorption also destabilized the protein, producing 505 
λ particles that were proficient at targeting different receptors.  506 
 507 
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[H2] Evolution of robustness. Variation in mutational robustness is found at all scales of biological 508 
organization, including the structures of macromolecules71,147, interactions between macromolecules and their 509 
ligands87,92, as well as the gene expression patterns of regulatory circuits167. Mutational robustness can 510 
therefore evolve. Moreover, it can evolve by various means; for example, via increased protein stability71 or 511 
via gene duplication74. 512 
 513 
Mutational robustness also has evolved, both in nature and in the laboratory. For example, the structures of 514 
eukaryotic microRNA precursor stem-loops are more robust to mutation than random RNA sequences with 515 
similar stem-loop structures168, and the mutational robustness of a protein’s tertiary structure tends to increase 516 
with the protein’s age169. Directed protein evolution has demonstrated that mutational robustness of 517 
cytochrome P450 proteins can increase in sufficiently large populations170, and experimental evolution of S. 518 
cerevisiae has demonstrated that gene duplications can confer mutational robustness74. 519 
  520 
We are not aware of experimental evidence that mutational robustness has evolved because it causes 521 
evolvability. By contrast, there is evidence that mutational robustness has evolved because it is itself 522 
adaptive171, for example in viral populations exposed to chemical mutagens, because robustness provides a 523 
competitive advantage when the mutation rate is elevated172. In addition, mutational robustness may often 524 
evolve as a by-product of other adaptations. For example, chaperones help maintain proteome integrity 525 
during environmental stress, and may buffer mutations only as a side effect. Similarly, the mutational 526 
robustness of eukaryotic microRNA precursor stem-loops is likely to be a by-product of selection for 527 
robustness of these RNA structures to temperature fluctuations173. 528 
 529 
[H2] Evolution of adaptive landscape topography. This cause of evolvability can also evolve: the location of 530 
an individual or a population on an adaptive landscape can change through DNA mutations or recombination, 531 
and because local landscape topography may differ in different locations, so may evolvability91,135,138,141,147,174-532 
176. A comparison of the fitness effects of mutations to three orthologous TIM barrel proteins provides an 533 
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illustrative example175. These proteins are distantly related, retaining only ~30–40% sequence identity, but 534 
they have the same fold and function. They therefore occupy different locations on the same adaptive 535 
landscape. These locations differ in their evolvability, because the same mutations have different, albeit 536 
correlated fitness effects in the three sequence backgrounds (locations). Another example is provided by the 537 
experimental evolution of two divergent yeast strains in the same laboratory conditions129. These strains, 538 
which differ at roughly 50,000 single nucleotide sites and therefore occupy different locations on their 539 
adaptive landscape, also differ in the rate at which they adapt evolutionarily — a proxy for evolvability129,177. 540 
Analysis of quantitative trait loci [G] partly attributes this difference in evolvability to a small subset of 541 
mutations, such as those involved in the ribosome biogenesis pathway. 542 
 543 
The evolvability conferred by a landscape’s local topography has also evolved. As shown in Fig. 2, for 544 
example, eleven substitutions occurred during the evolution of an ancient steroid hormone receptor, and this 545 
change in adaptive landscape location dramatically altered the spectrum of DNA-binding phenotypes 546 
accessible via mutation91. An additional example comes from Lenski’s long-term (>60,000 generations) 547 
evolution experiment with E. coli populations178. Here, one out of twelve populations evolved the ability to 548 
utilize citrate, and did so after 31,500 generations. The mutation needed to evolve citrate utilization conferred 549 
a fitness benefit even in the original ancestor of the experiment, but other mutations that occurred during the 550 
initial stages of the experiment conferred larger fitness benefits, and created a genetic background in which 551 
the initial citrate utilization-mutation no longer conferred a fitness benefit. Thus, evolution drove the 552 
population to a location on the adaptive landscape that precluded the evolution of citrate utilization. Only 553 
later did subsequent mutations bring the population back to a location where this mutation was adaptive. 554 
 555 
The same experiment also provides further evidence for evolving evolvability177. Within the first 500 556 
generations of this experiment, multiple genetically distinct subpopulations had evolved within a single 557 
population, meaning that the population had diversified from the location of the ancestral genotype to 558 
multiple new locations on the adaptive landscape. One of these subpopulations would eventually outcompete 559 
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the others, but it was not the subpopulation with the highest fitness. Rather, it was a subpopulation located in 560 
a region of the adaptive landscape that had higher evolvability. This was shown by ‘replay experiments’, in 561 
which 10 replicate populations were evolved from distinct founding subpopulations — that is, from distinct 562 
locations on the adaptive landscape. The subpopulation that would eventually outcompete the others 563 
generated more beneficial phenotypic variation than the other subpopulations — it had higher evolvability. 564 
After ~900 generations of evolution from these distinct landscape locations, the subpopulations evolved from 565 
the high-evolvability location tended to outcompete those evolved from other locations.  566 
 567 
We are not aware of experimental evidence that a population’s location on an adaptive landscape has evolved 568 
because it conferred evolvability. For instance, in the preceding example, evolvability evolved as a by-569 
product of the fixation of neutral or beneficial mutations that just happened to drive one of the subpopulations 570 
toward a high-evolvability region of the landscape177. Non-adaptive forces may also explain the evolution of 571 
a population’s location on an adaptive landscape. For example, the eleven substitutions that occurred during 572 
the evolution of an ancient steroid hormone receptor did not alter the protein’s binding specificity, which 573 
suggests that genetic drift caused this change in landscape location and the corresponding dramatic shift in 574 
evolvability90. An alternative possibility is that this change in landscape location was due to selection for 575 
protein function unrelated to binding specificity. 576 
 577 
Taken together, these examples show that the three causes of evolvability highlighted here — phenotypic 578 
heterogeneity, robustness, and adaptive landscapes — are themselves subject to evolutionary change. 579 
Whether they often evolve because they confer evolvability remains a particularly challenging open question. 580 
 581 
[H1] Outlook 582 
Driven by technological advances, research into all three causes of evolvability is progressing in leaps and 583 
bounds. We anticipate that this progress is going to continue unabated. For example, the currently well-584 
studied mechanisms to create non-genetic phenotypic heterogeneity that we discuss may well be only a small 585 
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subset of all pertinent mechanisms. Future work may reveal others to be important as well, such as RNA 586 
editing179 and protein allostery180. In addition, we know little about how conflicts of selection may influence 587 
the evolution of such mechanisms, especially in organisms that are not clonally related (Box 2). As for 588 
robustness, we understand its causes well for some systems like proteins or duplicate genes, but much less 589 
well for systems of greater complexity, such as gene regulatory circuits and metabolism. The evolutionary 590 
consequences of robustness become amply clear from detailed reconstructions of the evolution of molecules 591 
such as steroid hormone receptors91, but to date few such reconstructions are available. In the context of 592 
adaptive landscapes, we are only beginning to understand how landscape topography depends on higher-593 
order epistasis181,182. Moreover, although we know that the environment can affect adaptive landscape 594 
topography, we know little about how it does86,183. We are also only beginning to understand how our 595 
knowledge of landscape topography may facilitate the prediction of evolutionary trajectories109,184, or the 596 
deliberate redirection of evolving populations of pathogens toward low-evolvability regions of a landscape185.  597 
 598 
The three major causes of evolvability interact, but we do not fully understand how or to what effect. For 599 
example, phenotypic heterogeneity can smoothen an adaptive landscape, if a genotype’s overall fitness is 600 
equal to the average fitness of each of the phenotypes it brings forth33. Similarly, a DNA mutation that 601 
renders a protein’s phenotype robust to further mutations can be viewed as displacing the genotype to a 602 
smooth region of an adaptive landscape, where further mutations have smaller phenotypic effects. However, 603 
the degree of such ‘smoothing’ has not been explicitly characterized for any experimentally studied 604 
landscape. When an organism generates non-genetic adaptive variation in phenotypes, it creates two or more 605 
phenotypes from the same genotype, but any one adaptive phenotype can be stabilized by DNA mutations 606 
only if the starting genotype resides in a region of an adaptive landscape where some of its mutants provide 607 
such stabilization. We do not know the extent to which non-genetic mechanisms that create phenotypic 608 
variation and increase evolvability ensure that the variation they cause can be genetically stabilized. Finally, 609 
because a phenotype’s robustness to genetic and non-genetic change are often correlated69, genotypes that are 610 
especially robust to DNA mutations may also bring forth less phenotypic heterogeneity by non-genetic 611 
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means. If so, trade-offs between robustness and non-genetic mechanisms to create phenotypic heterogeneity 612 
may exist, and these trade-offs are well-worth exploring.  613 
 614 
A final frontier regards the evolution of the various evolvability mechanisms themselves. As we have shown, 615 
there is ample evidence that all three mechanisms can and do change in biological evolution. However, we 616 
have less information about whether their existence reflects an adaptive value of evolvability. Does increased 617 
mutational robustness at least sometimes come about because it enhances evolvability? Has the ruggedness of 618 
some adaptive landscapes decreased in the course of evolution, and if so, is it because reduced ruggedness 619 
increases evolvability? Questions like these are fascinating and profound, because an affirmative answer 620 
means that life itself can help create the conditions that ensure its advancement.  621 
 622 
Box 1 | Methodological advances 623 
Our ability to study the molecular causes of evolvability has been greatly improved by recent methodological 624 
advances. For example, our growing understanding of phenotypic heterogeneity is driven by microfluidic 625 
devices and time-lapse microscopy, which provide information about the compositions, morphologies and 626 
growth rates of single cells in dynamic environments186. Complementary information is provided by methods 627 
such as fluorescence in situ hybridization and single-cell RNA-seq, which describe the location and 628 
abundance of mRNA transcripts, respectively187,188. Combined with whole-genome sequencing, such methods 629 
have detailed the molecular causes of phenotypic heterogeneity, such as how stochastic gene expression 630 
drives persistence in bacteria26 and rare-cell variability in cancer24. Non-single-cell methodologies have also 631 
furthered our understanding of phenotypic heterogeneity. For example, ribosome footprint profiling, which 632 
characterizes the distribution of ribosomes on mRNA transcripts189, has detailed the prevalence of stop-codon 633 
readthrough in yeast, fly, and human39. 634 
 635 
Several methodological advances have improved our understanding of mutational robustness and of adaptive 636 
landscapes. For example, approaches that characterize a small region of an adaptive landscape typically rely 637 
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on deep mutational scanning139, a method that combines systematic mutagenesis with high-throughput 638 
phenotypic assays. These assays include fluorescence-activated cell sorting, which can be used to measure 639 
protein functions such as fluorescence or ligand binding, as well as EMPIRIC190, which can measure the 640 
fitness of many cells in parallel. To capture the effects of mutations in their native genomic context, genome-641 
editing tools such as CRISPR–Cas9 can be used to introduce mutations to specific chromosomal loci103. 642 
Approaches that exhaustively characterize an entire (small) genotype space have profited from chip-based 643 
technologies that simultaneously assay the phenotypes of all possible genotypes93, as well as from high-644 
throughput in vitro selection methodologies that systematically enrich an initially random library of 645 
sequences for those sequences that perform a particular function, such as binding a ligand147.  646 
To understand how these causes of evolvability have changed over long evolutionary timescales, they are 647 
often combined with maximum likelihood methods to statistically infer and experimentally reconstruct the 648 
genotypes and phenotypes of ancient macromolecules191. 649 
 650 
Box 2 | Conflicts between different levels of selection 651 
Biological systems are hierarchically organized, with macromolecules embedded in cells, cells in whole 652 
organisms, and organisms in populations. A genetic change that is beneficial on one level of this hierarchy 653 
may be detrimental on another. For example, because most random DNA mutations have detrimental effects 654 
on individuals or their offspring192, DNA mutations that increase the DNA mutation rate itself will also be 655 
detrimental for most individuals. By contrast, they may be advantageous for a population as a whole, 656 
especially in a stressful environment, where a few beneficial mutant individuals may ensure survival158,193 or 657 
accelerate adaptation156. Such conflicts are also relevant for the evolvability mechanisms we discuss, such as 658 
those that generate non-genetic heterogeneity, because in most environments such heterogeneity will not 659 
benefit all individuals15,22,25. Various approaches help predict how evolution can resolve such conflicts194-198. 660 
Among them are multi-level selection theory197 and kin selection theory196. The latter shows that higher, 661 
population-level adaptations can evolve and persist whenever populations consist of genetically highly 662 
related individuals, because in this case, the genetic ‘interests’ of individuals are aligned with those of the 663 
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population. It is relevant here that many known cases of adaptive non-genetic heterogeneity are found in 664 
clonal populations of genetically identical individuals15, where an individual’s interests are served as long as 665 
some of its clone-mates survive. Although theoretical work shows that evolvability mediated by prions such 666 
as [PSI+] may persist in non-clonal populations of the yeast Saccharomyces cerevisae85,199, extending such 667 
insights to other mechanisms of phenotypic heterogeneity, particularly non-heritable mechanisms, and to a 668 
broader range of organisms remains an important task for future work.  669 
 670 
With respect to robustness, the dual property to phenotypic heterogeneity, we note that it is often 671 
advantageous to an individual, for example when a mutation creates a thermodynamically more stable protein 672 
that is less prone to misfolding or inactivation170. Wherever this is the case, the individual-level advantage 673 
and the population-level advantage of evolvability are aligned. This makes robustness a cause of evolvability 674 
whose evolutionary origin need not involve conflict, and is thus especially easy to explain. At the same time, 675 
this absence of conflict also means that it is more difficult to disentangle whether the robustness of any one 676 
trait originated in an individual-level advantage, such as the robustness that chaperones provide to 677 
proteomes200, or in a ‘second-order’ advantage of evolvability, which chaperones also provide82.  678 
 679 
Figure legends 680 
Figure 1 | Phenotypic heterogeneity is a cause of evolvability. a | Phenotypic heterogeneity can generate 681 
a small subpopulation of cells that exhibits a new phenotype, such as a persister phenotype (red cells in 682 
environment 1). Such a phenotype can be adaptive, because it allows a subpopulation to survive an 683 
environmental challenge, such as antibiotic exposure (environment 2). Mutation (red cross) may stabilize the 684 
phenotype, or it may generate a different phenotype that is adaptive in the new environment, such as a 685 
mutation that confers resistance to an already tolerant bacterial cell. There are many sources of phenotypic 686 
heterogeneity: b | Stochastic gene expression causes mRNA transcript levels to vary among cells. c | Errors 687 
in protein synthesis, such as mistranslation, cause variation in the amino acid sequences of proteins that are 688 
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translated from the same mRNA transcript. d | Epigenetic modifications, such as the yeast prion [PSI+], 689 
cause variation in protein sequences, in this example via stop-codon readthrough. 690 
 691 
Figure 2 | Robustness causes evolvability by providing access to a diversity of mutational 692 
neighbourhoods. a,b | The mutational neighbourhoods of the ancestral steroid receptor (AncSR1 in ref 91; 693 
part a) and the derived steroid receptor after 11 amino acid changes (AncSR1+11p in ref 91; part b). Each 694 
vertex (circle) corresponds to a sequence of amino acids at four sites in each protein’s recognition helix: the 695 
three that historically changed binding specificity, plus an adjacent site. Of all 160,000 possible such 696 
sequences in each background, only functional sequences are shown — i.e., sequences that bind the oestrogen 697 
(pink) or the steroid (blue) response elements, or that promiscuously bind both (yellow). Edges connect 698 
sequences that differ in a single amino acid. The number of functional sequences differs dramatically 699 
between the two backgrounds: 129 in the ancestral background, as compared to 1,351 in the derived 700 
background. c,d | Moreover, the lengths of the shortest paths from a sequence that binds the oestrogen 701 
response element to a sequence that binds the steroid response element is much longer in the ancestral 702 
background (part c) than in the derived background (part d). The * symbol indicates starting points from 703 
which there is no path to a sequence that binds the steroid response element. Data from ref 91. [Copy Ed: no 704 
credit line is needed for actual figure adaptation. Although the data are derived from Ref91, the figures 705 
themselves are not from there (or even from the supp info of the original article). It’s also Nature 706 
anyway, so no formal copyright clearance would be needed anyway.] 707 
 708 
Figure 3 | Adaptive landscape topography influences evolvability. a | A smooth, single-peaked 709 
landscape facilitates evolvability, because mutations can create adaptive phenotypic variation from anywhere 710 
in the landscape, except atop the global peak. For example, the white and black circles denote two distinct 711 
mutational paths that start from different points in the landscape, but that both converge on the global peak 712 
via a series of ‘uphill’ mutational steps. b | By contrast, a multi-peaked, or rugged landscape hinders 713 
evolvability, because an evolving population may become trapped on local, suboptimal peaks. For example, 714 
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whereas the mutational path indicated by the white circles leads to the global peak, the mutational path 715 
indicated by the black circles does not. c | The shape of an adaptive peak is a consequence of magnitude 716 
epistasis. Specifically, positive epistasis generates peaks that are convex, whereas negative epistasis generates 717 
peaks that are concave. As a population climbs an adaptive peak, evolvability tends to increase if the peak is 718 
convex, whereas it tends to decrease if the peak is concave. d | Landscape ruggedness is a consequence of 719 
sign epistasis, which creates adaptive valleys that may be difficult for an evolving population to cross. Grey 720 
circles correspond to those in part b. e-g | The same landscape as in part a, but shown as two-dimensional 721 
contour plots. Open circles indicate genotypes and edges connect genotypes that differ by a single mutation. 722 
The same landscape can be studied by: systematically engineering genotypes that contain all possible 723 
combinations of a small number of mutations (part e); deep mutational scanning of a single wild-type 724 
genotype, including all single-mutants, many double-mutants, and some triple-mutants (part f); or in the case 725 
of small landscapes, via the exhaustive enumeration of all possible genotypes (part g).  726 
 727 
Glossary 728 
Isogenic populations 729 
Populations of individuals with the same genotype.  730 
 731 
Phenotypic plasticity 732 
The ability of one genotype to produce more than one phenotype in response to different environmental stimuli. 733 
 734 
Modularity 735 
The extent to which a system can be partitioned into distinct components. 736 
 737 
Pleiotropy 738 
When one gene or one mutation affects multiple phenotypes. 739 
 740 
Pre-mutation evolvability 741 
 30 
Evolvability driven by new mutations. 742 
 743 
Post-mutation evolvability 744 
Evolvability driven by existing genetic variation within a population, for example via recombination acting on that 745 
variation. 746 
 747 
Gene expression noise 748 
Variability among isogenic cells in transcript or protein abundance. 749 
 750 
Viral latency 751 
The ability of a virus to remain dormant in a host cell. 752 
 753 
Competence 754 
The ability of a cell to take up DNA from the environment. 755 
 756 
Tolerance 757 
The ability of bacteria to survive in the presence of antibiotics without developing resistance. 758 
 759 
Population bottleneck 760 
A temporary, drastic reduction in population size. 761 
 762 
Genetic assimilation 763 
A process by which a new phenotype that results from an environmental perturbation becomes genetically encoded. 764 
 765 
Kinetic trapping 766 
Occurs when a protein does not reach its minimum free-energy structure, but rather becomes trapped in a non-767 
equilibrium structure. 768 
 769 
Stop-codon readthrough 770 
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When translation does not terminate at a stop codon, but rather continues to extend an amino acid chain. 771 
 772 
Prions 773 
Proteins that propagate by inducing properly folded proteins to convert into a misfolded form, often resulting in 774 
aggregation.  775 
 776 
Cryptic genetic variation 777 
Genetic variation that normally causes little to no phenotypic variation, but that has the potential to cause phenotypic 778 
variation in new environments or new genetic backgrounds. 779 
 780 
Enhancer 781 
A short DNA sequence that is bound by regulatory proteins to activate the transcription of a gene, which may be located 782 
many thousands of base pairs away. 783 
 784 
Chaperones 785 
Proteins that assist other proteins in folding, or refold misfolded proteins. 786 
 787 
Epistatic interactions 788 
Non-additive interactions between alleles in their contribution to a phenotype or fitness. 789 
 790 
Protein domain 791 
A distinct functional and often autonomously folding unit of a protein. 792 
 793 
Genotype space 794 
The space of all possible genotypes. For a nucleic acid sequence of length L, this space comprises 4L genotypes. 795 
 796 
Concave 797 
A real-valued function on an interval of real numbers is concave if any line connecting two points on the graph of the 798 
function lies on or below the graph. 799 
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 800 
Convex 801 
A real-valued function on an interval of real numbers is convex if any line connecting two points on the graph of the 802 
function lies above or on the graph. 803 
 804 
Adaptive walks 805 
A series of mutations that never decrease fitness. 806 
 807 
Saddle points 808 
Points on a landscape that have zero slope in at least two orthogonal directions, yet are not local peaks. 809 
 810 
Extra-dimensional bypasses 811 
Accessible mutational paths to an adaptive peak that are faciltated by increasing the dimensionality of an adaptive 812 
landscape. 813 
 814 
Quantitative trait loci 815 
Loci that explain part of the genetic basis of variation in a phenotype. 816 
 817 
Key points 818 
• Evolvability is the ability of a biological system to produce phenotypic variation that is both heritable 819 
and adaptive. 820 
• Recent technological advances are transforming evolvability research from a field dominated by 821 
theory to one illuminated by experiment. 822 
• We highlight three causes of evolvability that have been the focus of recent experimental research. 823 
They are phenotypic heterogeneity, robustness, and adaptive landscape topography. 824 
• We discuss the mounting evidence that these causes of evolvability can evolve, and also the question 825 
of whether they can evolve adaptively. 826 
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